Hospital Clinico Universitario Lozano Blesa — Clinical Trial Site

169 Registered trials

66 Currently recruiting

Organisation

Hospital Clinico Universitario Lozano Blesa

Location

Zaragoza, Spain

Identifier

ORG-100041561

Address

Avenida De San Juan Bosco 15, 50009, Spain

Departments

034039: Oncología Médica
1209:Oncología Médica
1326: Hematologia
7003: Oncologia
7101:Oncología
7103: Hematologia
724005: Oftalmología
724022: Oncología
Allergology
Aparato Digestivo
Cardiología
Cardiology
Cirugía
Clinical Haematology
Coloproctología
Department of Oncology
Dermatology
Digestive
Digestive system
Digestivo
Division of Infectious Diseases
ES10009: Hematología
ESP004: Oncología
Gastroenterología
Gynecología Oncológica
Hematologia
Hematology
Hospital Clínico Universitario Lozano Blesa Hospital Clínico Lozano Blesa (#1)
Infectious Diseases
Internal Medicine
Medical Oncology
Medicina Interna
N/A
Neurología
Neurology
Oftalmologia
Oncologia
Oncología Médica
Oncology
Oncology Department
Oncology Service
Ophtalmology
Ophthalmology
Ophthalmology service
otorhinolaryngology department
Pediatric
Pneumology
Pulmonary
Servicio de digestivo
Servicio de Aparato Digestivo, Unidad de Enfermedad Inflamatoria Intestinal
Servicio de Dermatología
Servicio de Digestivo
Servicio de Enfermedades Infecciosas
Servicio de Hematologia
Servicio de Infecciosas
Servicio de Neurología
Servicio de Oftalmologia
Servicio de Oncología
Servicio de Oncología Médica
Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva.
Unidad de Investigación Traslacional-Ensayos Clínicos Oncologia Medica
Urology

Clinical trials at this site (169)

Search interface

A Phase 3 study of NBTXR3 with or without cetuximab in LA-HNSCC Recruiting

2024-520386-31-00 Locally Advanced Head & Neck Squamous Cell Carcinoma 5 2025-09-22
A Phase 1 study of GSK5764227 in participants with advanced solid tumors Recruiting

2024-513663-10-01 Neoplasms 3 2025-09-17
Durvalumab after definitive chemoradiotherapy in limited stage small cell lung cancer Recruiting

2025-521340-37-00 small cell lung cancer 5 2025-07-24
A PHASE 2 STUDY TO RESEARCH THE SAFETY AND EFFICACY OF TRASTUZUMAB DERUXTECAN VERSUS CDK4/6I PLUS ENDOCRINE THERAPY IN ADVANCED BREAST CANCE… Recruiting

2024-512360-55-00 Unresectable locally recurrent or metastatic hormone re 4 2025-06-30
Safety, efficacy, and pharmacokinetics of BNT327 in combination with chemotherapy and other investigational agents for lung cancer Recruiting

2024-515764-31-00 Non-small cell lung cancer 10 2025-06-13
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (… Recruiting

2023-510294-34-00 small lymphocytic lymphoma (SLL) 5 2025-06-12
A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of ELGN-2112 o… Recruiting

2024-517101-87-00 Intestinal Malabsorption 5 2025-05-26
A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge… Recruiting

2023-509547-27-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2025-05-22
A Study to Assess the Effectiveness and Safety of Induction Therapy with RO7790121 in Participants with Moderately to Severely Active Crohn'… Recruiting

2024-513054-30-00 Moderately to Severely Active Crohn's Disease (CD) 5 2025-04-16
Long-term Extension Study for Participants with Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 … Recruiting

2022-500747-21-00 Geographic Atrophy 4 2025-02-27
Effect of pharmacological treatment with angiotensin receptor/neprilysin inhibitors on transthyretin cardiac amyloidosis and heart failure w… Recruiting

2024-515661-34-00 Transthyretin cardiac amyloidosis 6 2025-02-27
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients with Operable No… Recruiting

2023-509806-31-00 Non-Small Cell Lung Cancer 4 2025-02-11
The role of intra-abdominal pressure and point of care ultrasound to guide decongestive therapy in Heart Failure (ABDOPOCUS-HF) Recruiting

2024-512901-22-00 Acute Heart Failure 5 2025-02-10
Continuing Anticoagulants and Antiplatelets in Cold snare Polypectomy. Recruiting

2024-511265-11-01 patients who are requested a colonoscopy for any indica 6 2024-11-19
Effect of obesity due to the action of aspirin and its effectiveness in therapy for the treatment of colon cancer. Recruiting

2024-515251-37-00 Colorectal cancer 4 2024-11-05
Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH (ENLIGHTEN-Cirrhosis) Recruiting

2023-510395-31-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5 2024-10-30
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Heart condition 5 2024-10-08
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects with Moderately to Severely Active Crohn's Dis… Recruiting

2023-509618-12-00 Crohn's Disease (CD) 5 2024-09-11
Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting

2023-508442-18-00 Patients with an infection of the osteosynthesis materi 5 2024-04-14
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Recruiting

2023-504031-41-00 ER+/HER2- Early Breast Cancer 5 2024-03-25
A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF)… Recruiting

2023-504323-25-01 breast cancer 5 2024-03-19
RECOVERY Recruiting

2023-507441-29-00 Pneumonia 5 2024-02-29
Trial to Better Characterize the Status of HRD leading to a Benefit from Olaparib in Combination with Bevacizumab in Patients with Advanced … Recruiting

2024-517363-24-00 Advanced FIGO Stage III‐IV High Grade Serous or Endomet 4 2024-02-16
A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting

2022-502113-28-00 Follicular lymphoma 5 2024-02-01